A recent study of the video-game-based treatment that focused on adults with ADHD found that EndeavorRx boosted their sustained and selective attention at a rate nearly seven times that of the ...
Lumos Labs, creators of the popular Lumosity brain training platform with over 100 million users, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ...
EndeavorRx is authorized for use to improve attention function in adolescents with primarily inattentive or combined-type ADHD. The Food and Drug Administration (FDA) has expanded the approval of ...
Akili (NASDAQ:AKLI) stock rose ~38% on Wednesday after the company reported results from a trial of video game-based therapy EndeavorRx to treat adults with attention ...
Attention improvements were nearly three times as large as those in the pivotal trial that served as the basis for EndeavorRx’s FDA authorization for children with ADHD ages 8-12 Study data will be ...
Please provide your email address to receive an email when new articles are posted on . A digital medicine company has revealed positive topline results of an expansionist study evaluating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results